Ventavia Research Group — Fort Worth, Texas

Ventavia Research Group is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Ventavia Research Group has participated in 11 clinical trials.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, Episodic Migraine.

Sponsors: BioNTech SE, Allergan, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ventavia Research Group?

Ventavia Research Group has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ventavia Research Group conducted?

Ventavia Research Group has 11 clinical trials on record. Their work covers SARS-CoV-2 Infection, COVID-19, Episodic Migraine.

Is Ventavia Research Group accredited by Crixeo Health?

Yes — Ventavia Research Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Ventavia Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.